T3SLA Innovations Creating Opportunity

The United States has experienced problems with drug abuse for decades, but there has been almost no wave of abuse so devastating as the Opioid Epidemic of the last 30 years. An unfortunate truth is that many people who suffer from opioid addiction began as patients who were over-prescribed opiates by doctors who had financial incentives to provide medications such as OxyContin, Codeine, and Vicodin. Since the prescription quantity was excessive at the start, the patient unknowingly forms a dependence and is put at a disadvantage after the prescription has been used up. From 1999–2018, almost 450,000 people died from an overdose involving any opioid, including prescription and illicit opioids. Shockingly, of the nearly 70,000 drug overdoses in the United States in 2018, 46,802 were due to opiate overdose. Yet, efforts to address the way this disease is ravishing the country have been limited, with the vast majority of drug users finding themselves in the hands of the law instead of a medical professional.
A survey conducted by our team in New Orleans found that approximately 80% of opioid overdose deaths occurred when individuals were alone, where there was no one present to administer Naloxone or call for help. More than half of the remaining 20% of cases took place in the company of someone else who was also incapacitated by drug use, or otherwise unaware of the overdose that was occurring, including cases where individuals present were alseep. The data shows that an overwhelming majority of these deaths, rather than being declared DOA, were preventable in some manner if the correct resources were available, and action taken during a critical timeframe in which emergency responders are rarely able to respond within.
Throughout the spreading surge of the opioid epidemic, a growing number of families and friends are left wondering if there was anything that they could have done to save their loved one’s life. Our team at T3SLA Innovations (the R&D division of Slack Enterprises, LLC) is dedicated to making sure we never have to ask that question again.

HOW?

LifeWatch is the first device designed to detect opioid overdose in individuals, and automatically administer an appropriate dose of Naloxone—a safe and effective opioid-reversal drug in wide use today for by paramedics and ER doctors. Naloxone reverses/blocks the opioid’s affects when it binds with opioid receptors in the brain, and can quickly restore normal respiration to someone whose breathing has slowed or stopped.

The LifeWatch is designed to look, feel, and fit like a smart watch, with a monitoring pad that sits flush with the top of the wrist. By collecting samples of normal heart rate, blood pressure, and dissolved oxygen levels through the optical sensor and monitoring pad and back testing on continual loop, LifeWatch will be able to determine when a wearer is in a state of overdose through sudden drops or abnormalities, aided by the monitoring of movement. The vitals can be viewed, stored, and tracked on the LifeGuard App, which syncs with the LifeWatch.
The LifeGuard App will also store the Emergency Contacts for when the device triggers a distress call. After an OD signal has been generated and processed, LifeWatch will administer a single dose (MG REQUIRED) of Naloxone intravenously through the top of the wrist using a concentrated high-pressure burst. LifeWatch will then call the Emergency Contact that is linked to the LifeGuard App (or 911 if there is no assigned Emergency Contact or the user does not have the app). It is recommended that users be under medical supervision for at least 2 hours after the dose is administered to ensure stabilization, particularly in light of powerful opioids like Fentanyl making their way into black market drugs.

Sign Up to Our Newsletter!
Sign up to our newletter to be updated weekly on our progress.

Our development team

Our development team includes engineers and scientists from ABET accredited universities. We also have skilled professional engineers and medical professionals who oversee the development of the LifeWatch band. LifeWatch falls under a Slack Enterprises, LLC patent. T3SLA Innovations Inc. is the Research and Development Division of Slack Enterprises, and an upstanding startup founded by Loyola University graduates, striving to mobilize comprehensive technical solutions that address neglected or overlooked issues and problems. The most concerning problems usually have a disproportionately greater impact on marginalized groups and populations, and T3SLA's mission centers on uniting communities to deploy solutions and maximize their effectiveness and overall impact potential. Additionally, established in 2002, Slack Enterprises, LLC is a family-operated professional engineering firm in New Orleans, LA comprised of a team of five associate engineers with over 60 years of combined experience in every major field of engineering. As of 2020, this company operates as susidiary company of T3SLA Innovations Inc.

The engineering and physicist associates at Slack Enterprises are dedicated to providing the very best in product solutions to the world's everyday problems. They come to work each day and coordinate as a team, examining the origins and elements of the problems you face in your everyday life. Upon identifying and defining a specific problem, the team works with the T3SLA community to aid in developing a comprehensive product solution that targets the core elements of the problem and, whenever possible, engages affected communities to unify and work together in solution deployment to achieve the greatest results. There is no problem that we cannot solve when we work together.

Key people for T3SLA Innovations

Thomas Slack
Interim-CEO Founder
John Whyte
Interim Chief Operational Officer Co-Founder
Riley Mayes
Chief Science Officer Co-Founder

Assets for LifeWatch Brand

Support our Cause with the LifeWatch Assets
Download brand assets
© Copyright 2021 by Slack Enterprises, LLC and T3SLA Innovations Inc. T3SLAinc.com, All Rights Reserved.